Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report released on Tuesday morning. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Up 6.1 %

NYSE:ENZ opened at $0.51 on Tuesday. Enzo Biochem has a 1 year low of $0.41 and a 1 year high of $1.40. The business has a 50 day simple moving average of $0.71 and a 200-day simple moving average of $0.97.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) earnings per share (EPS) for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Wittenberg Investment Management Inc. grew its stake in Enzo Biochem by 60.1% during the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after buying an additional 70,400 shares during the last quarter. Virtu Financial LLC purchased a new position in Enzo Biochem during the 4th quarter worth $35,000. Lepercq Multi Asset Fund purchased a new position in Enzo Biochem during the 4th quarter worth $88,000. Geode Capital Management LLC grew its stake in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after buying an additional 11,742 shares during the last quarter. Finally, BBR Partners LLC purchased a new position in Enzo Biochem during the 3rd quarter worth $112,000. 36.90% of the stock is currently owned by hedge funds and other institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.